See the DrugPatentWatch profile for methotrexate

The Impact of Methotrexate on Older Adults' Kidney Function: A Comprehensive Review

As the global population ages, the use of methotrexate, a commonly prescribed medication for rheumatoid arthritis, psoriasis, and other autoimmune disorders, is becoming increasingly prevalent among older adults. While methotrexate is generally well-tolerated, it can have a significant impact on kidney function, particularly in older adults. In this article, we will delve into the effects of methotrexate on older adults' kidney function, exploring the risks, mechanisms, and potential consequences.

What is Methotrexate?

Methotrexate is a disease-modifying antirheumatic drug (DMARD) that has been widely used for decades to treat various autoimmune disorders, including rheumatoid arthritis, psoriasis, and inflammatory bowel disease. It works by inhibiting the enzyme dihydrofolate reductase, which is essential for the production of tetrahydrofolate, a crucial molecule in the synthesis of DNA and other biomolecules.

How Does Methotrexate Affect Kidney Function?

Methotrexate can affect kidney function in several ways:

Mechanisms of Kidney Damage

Methotrexate can cause kidney damage through several mechanisms:

Direct Toxicity

Methotrexate can directly damage kidney cells, leading to nephrotoxicity. This is particularly concerning in older adults, who may have pre-existing kidney disease or decreased kidney function.

Inflammation

Methotrexate can also cause inflammation in the kidneys, leading to increased oxidative stress and damage to kidney tissue.

Hypertension

Methotrexate can increase blood pressure, which can further exacerbate kidney damage and dysfunction.

Risk Factors for Kidney Damage

Several risk factors can increase the likelihood of kidney damage in older adults taking methotrexate:

Age

Older adults are more susceptible to kidney damage due to decreased kidney function and increased sensitivity to medication.

Pre-existing Kidney Disease

Individuals with pre-existing kidney disease are at a higher risk of developing kidney damage from methotrexate.

Other Medications

Concurrent use of other nephrotoxic medications, such as nonsteroidal anti-inflammatory drugs (NSAIDs), can increase the risk of kidney damage.

Dose and Duration

Higher doses and longer durations of methotrexate therapy can increase the risk of kidney damage.

Consequences of Kidney Damage

Kidney damage caused by methotrexate can have significant consequences, including:

Chronic Kidney Disease

Prolonged exposure to methotrexate can lead to chronic kidney disease, which can progress to end-stage renal disease (ESRD).

Acute Kidney Injury

Methotrexate-induced kidney damage can also cause acute kidney injury, which can be life-threatening.

Increased Risk of Infections

Kidney damage can increase the risk of infections, particularly in older adults with compromised immune systems.

Increased Risk of Cardiovascular Disease

Chronic kidney disease and kidney damage can increase the risk of cardiovascular disease, including heart failure, stroke, and peripheral artery disease.

What Can Be Done to Mitigate the Risk of Kidney Damage?

To mitigate the risk of kidney damage, healthcare providers and patients can take several steps:

Monitoring Kidney Function

Regular monitoring of kidney function, including blood urea nitrogen (BUN) and creatinine levels, can help identify early signs of kidney damage.

Dose Adjustment

Adjusting the dose of methotrexate based on kidney function can help minimize the risk of kidney damage.

Concurrent Medications

Careful selection of concurrent medications can help minimize the risk of kidney damage.

Patient Education

Educating patients about the risks and benefits of methotrexate and the importance of regular monitoring can help improve adherence and outcomes.

Conclusion

Methotrexate is a commonly prescribed medication for various autoimmune disorders, but it can have a significant impact on kidney function, particularly in older adults. Understanding the mechanisms of kidney damage, risk factors, and consequences can help healthcare providers and patients take steps to mitigate the risk of kidney damage. By monitoring kidney function, adjusting doses, selecting concurrent medications, and educating patients, we can improve outcomes and reduce the risk of kidney damage in older adults taking methotrexate.

Key Takeaways

* Methotrexate can cause kidney damage through direct toxicity, inflammation, and hypertension.
* Older adults are at a higher risk of kidney damage due to decreased kidney function and increased sensitivity to medication.
* Pre-existing kidney disease, concurrent use of other nephrotoxic medications, and higher doses and longer durations of methotrexate therapy can increase the risk of kidney damage.
* Kidney damage caused by methotrexate can have significant consequences, including chronic kidney disease, acute kidney injury, increased risk of infections, and increased risk of cardiovascular disease.

FAQs

1. What is the most common side effect of methotrexate?
Answer: Nausea and vomiting.

2. What is the recommended dose of methotrexate for older adults?
Answer: The recommended dose of methotrexate for older adults is typically lower than for younger adults.

3. What is the most common cause of kidney damage in older adults taking methotrexate?
Answer: Direct toxicity is the most common cause of kidney damage in older adults taking methotrexate.

4. Can methotrexate cause kidney damage in individuals with normal kidney function?
Answer: Yes, methotrexate can cause kidney damage in individuals with normal kidney function, particularly at higher doses and longer durations of therapy.

5. What is the recommended frequency of kidney function monitoring in older adults taking methotrexate?
Answer: The recommended frequency of kidney function monitoring in older adults taking methotrexate is typically every 3-6 months.

Sources

1. DrugPatentWatch.com. (2022). Methotrexate Patent Expiration. Retrieved from <https://www.drugpatentwatch.com/patent-expiration-date/methotrexate>

2. National Institute of Arthritis and Musculoskeletal and Skin Diseases. (2022). Methotrexate. Retrieved from <https://www.niams.nih.gov/health-topics/methotrexate>

3. American College of Rheumatology. (2022). Methotrexate. Retrieved from <https://www.rheumatology.org/I-Am-A-Patient/Conditions/Methotrexate>

4. National Kidney Foundation. (2022). Kidney Disease and Methotrexate. Retrieved from <https://www.kidney.org/atoz/content/kidney-disease-and-methotrexate>

5. European Medicines Agency. (2022). Methotrexate. Retrieved from <https://www.ema.europa.eu/en/medicines/human/referrals/methotrexate>

Note: The sources cited are subject to change and may not be exhaustive.